Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations
about
Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic StudiesThe obesity pandemic: where have we been and where are we going?Association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma gene and strength athlete status.The association between the Pro12Ala variant in the PPARγ2 gene and type 2 diabetes mellitus and obesity in a Chinese populationEpigenetic effects of human breast milk.Therapeutic Implications of PPARgamma in Human Osteosarcoma.Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator.The Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma Gene Modifies the Association of Physical Activity and Body Mass Changes in Polish Women.Genetic determinants of type 2 diabetes mellitus.Genetics of leptin and obesity: a HuGE review.Inference of cross-level interaction between genes and contextual factors in a matched case-control metabolic syndrome study: a Bayesian approachStudies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approachFatty acids and the metabolic syndrome.Consequences of food energy excess and positive energy balance.PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility.PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?PPARγ2 polymorphism and human health.Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications.The genetic interface between gestational diabetes and type 2 diabetes.Obesity and eating behaviour in children and adolescents: contribution of common gene polymorphisms.Association between PPAR-γ2 Pro12Ala polymorphism and obesity: a meta-analysis.Association of the peroxisome proliferator-activated receptor-gamma2 Pro12Ala but not the C1431T gene variants with lower body mass index in Type 2 diabetes.The Rate of Decline of Glomerular Filtration Rate May Not Be Associated with Polymorphism of the PPARγ2 Gene in Patients with Type 1 Diabetes and Nephropathy.Peroxisome proliferator-activated receptor gamma polymorphism and periodontitis in pregnant Japanese women.The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma (PPARG) gene in relation to obesity and metabolic phenotypes in a Taiwanese population.Dietary fat intake and polymorphisms at the PPARG locus modulate BMI and type 2 diabetes risk in the D.E.S.I.R. prospective study.Pro12Ala polymorphism in human peroxisome proliferator activated receptor gamma is associated with hyperlipidaemia in obstructive sleep apnoea hypopnoea syndrome.Novel neuropeptide Y1 and Y5 receptor gene variants: associations with serum triglyceride and high-density lipoprotein cholesterol levels.Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals.Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population.Correlation of peroxisome proliferator-activated receptor (PPAR-γ) mRNA expression with Pro12Ala polymorphism in obesity.Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-gamma2 Pro12Ala genotype.The Q121 variant of ENPP1 may protect from childhood overweight/obesity in the Italian population.Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-gamma2 gene polymorphisms.PPARγ2 gene Pro12Ala and PPARα gene Leu162Val single nucleotide polymorphisms interact with dietary intake of fat in determination of plasma lipid concentrations.Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.Association of PPAR-γ gene polymorphisms with obesity and obesity-associated phenotypes in North Indian population.Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.
P2860
Q24791420-24582D10-C100-4F73-B899-D47F96A99021Q28221639-DE5466D2-AC28-495C-B19F-8205E4308900Q30349835-3AFD677D-9BBF-4E39-9566-FF38EEA20BAAQ31121358-3C21E22A-EE99-45A2-9AFE-CE314D636C98Q31132059-47709BBD-844B-4414-A5E8-1CDA9EB16552Q33570511-0964A745-0A69-4A84-98A4-621A22070FF1Q33674615-00AED629-D081-4D34-8711-62B96D7E0A76Q33780711-861B9CE8-3232-4281-8434-A3691E8384E3Q34412598-F93EA034-DE7E-4E1C-8F20-88F4617227C4Q34421519-E7E2F330-C7E7-497F-997A-C033C6A3075AQ34428366-811F587D-282B-4B38-BD9D-8CBAB622125AQ34599296-34621D0E-521E-4075-877A-8FF1670B3796Q35104849-BF15687D-9CC4-4841-B1A2-58B8C0797FC0Q36118732-E5854D4B-7972-4128-A248-5F5B62A2C7E9Q36309322-07A64283-EC16-4CB0-9C56-599AB689C2C0Q36465006-649D04E2-9975-4890-8C16-164196550B85Q36889164-10BD3B2F-F406-4037-9FDF-8EF54CEE2B9DQ37159796-3DE28A20-B95C-4840-905B-53F5E5B9CC9FQ37404625-4DD0DF05-0919-42C2-89CC-F3F084144ABDQ37965227-5EF5FB32-429E-49BA-AFE8-1F95634DAB02Q38020893-81356C35-7A56-424D-8EEF-F86131BF723AQ38393224-0596962D-83EA-4DD8-A533-1985AE6B15EFQ39258427-E228A096-FCCC-4C9B-B03A-7EB71EFF0971Q41824160-CB8DAABF-4348-47EC-80C9-1B1DEE879A9BQ43070100-C7EC8614-7763-44CE-9C30-2D174A5C923AQ43704491-7A876046-B93C-4268-B179-52D5DABF3758Q43900723-531C6E86-BB8E-48C6-839A-454C5303B316Q43953982-A347986E-4ECE-40E6-98D0-A7854D32F5BFQ44130740-89BE2220-658D-48AE-A461-B859E7ED5343Q44158440-3B7EEB83-FE9B-4B37-BCC7-345D9F093CF3Q44210344-2B070096-6AD2-4D08-854B-6CEFAAF9C4FFQ44365416-6DA2878F-6764-4469-911C-AB148DD80B3FQ45261100-2ED240BC-D62F-4C87-8EA6-67CB69B5202EQ46299618-E304045E-D99C-42F8-9FC4-732CCE6A40F1Q46826968-4C8FEB4C-31EE-4F3C-9CF7-F3030AE427FDQ47314458-C36E8018-715F-425D-9113-BFDD3A784D47Q49169034-00D12F1C-3516-4DBF-B0AD-A303519E7938Q51473059-00D5B196-F99A-479B-AD9D-1F6F7D6A6962Q54319581-15E329C4-1324-41DF-8C58-E742020322C2Q54596205-5F301C01-CF49-46A3-9838-FC89E356147F
P2860
Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations
description
article
@en
im November 1998 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 1998
@uk
name
Association of the Pro12Ala va ...... y in two Caucasian populations
@en
Association of the Pro12Ala va ...... y in two Caucasian populations
@nl
type
label
Association of the Pro12Ala va ...... y in two Caucasian populations
@en
Association of the Pro12Ala va ...... y in two Caucasian populations
@nl
prefLabel
Association of the Pro12Ala va ...... y in two Caucasian populations
@en
Association of the Pro12Ala va ...... y in two Caucasian populations
@nl
P2093
P1433
P1476
Association of the Pro12Ala va ...... y in two Caucasian populations
@en
P2093
B A Beamer
L J Cheskin
R E Andersen
P304
P356
10.2337/DIABETES.47.11.1806
P407
P577
1998-11-01T00:00:00Z